Hunt Hazel bought CORT

February 9, 2026 · Form 4 insider transaction

Hunt Hazel bought 150,000 shares of Corcept Therapeutics Incorporated at $3.88 per share, a transaction worth $582.0K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.